IRVINE, Calif., Nov. 17, 2003 (PRIMEZONE) -- WallStreetAudio.com recently posted an exclusive interview with Dr. Irit Arbel, CEO of Pluristem Life Sciences, Inc. (OTCBB:PLRS).
The interview can be heard on http://www.WallStreetAudio.com.
The interview discusses the Company's recent Patent approval of its PluriX(tm) Plug Flow Bioreactor in Australia and the uniqueness of their technology in the advancement of stem cell research. The interview also provides a good overview of stem cell technologies and advancements.
About Pluristem
Pluristem is a biotechnology company dedicated to the development of stem cell expansion technology. The Company is concentrating on the expansion of cord blood hematopoietic stem cells (blood and immune system cells) to provide vital stem cell expansion services to blood banks and transplants centers in the U.S. and Europe.
About WallStreetAudio.com
WallStreetAudio.com (WSA) is an Internet financial news and information portal focused on corporate disclosure and transparency. WSA produces compelling audio interviews with top management from U.S. based public companies and industry specific educational symposiums for the investment community. Distribution in the U.S. is through the www.WallStreetAudio.com website and through partnerships in Europe and other parts of the world.
Utilizing streaming audio technologies, WSA brings the investment community relevant and timely information from companies who wish to provide investor's with regular access to important information. WSA is free to the public.
The statements contained in this press release and in the audio interviews referenced herein that are not purely historical are forward-looking statements within the meaning of Section 37A of the Securities Exchange Act of 1934, including statements regarding the company's hopes, beliefs, intentions, or strategies regarding the future. Forward-looking statements include, but are not limited to, expectation of growth rates, new business, and acquisitions. Cinapsys, Inc., WallStreetAudio.com's parent company was compensated for the audio interview. Please refer to the disclaimer on the website.